🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/01/2008 | 17,44 | 17,74 | 16,96 | 17,22 | -2,75% | 4,51% | 135.373 |
| 03/01/2008 | 18,53 | 18,53 | 17,40 | 17,70 | -2,67% | 6,06% | 124.366 |
| 02/01/2008 | 17,97 | 18,71 | 17,97 | 18,19 | +0,62% | 4,17% | 130.110 |
| 31/12/2007 | 18,45 | 18,57 | 17,97 | 18,08 | -3,21% | 3,25% | 176.677 |
| 28/12/2007 | 18,53 | 19,05 | 18,38 | 18,68 | +1,63% | 3,64% | 156.720 |
| 27/12/2007 | 20,40 | 20,40 | 18,34 | 18,38 | -8,40% | 10,09% | 158.430 |
| 26/12/2007 | 21,22 | 21,41 | 19,91 | 20,06 | -7,43% | 7,05% | 176.250 |
| 24/12/2007 | 20,85 | 21,78 | 20,47 | 21,67 | +5,66% | 6,28% | 592.389 |
| 21/12/2007 | 20,36 | 21,04 | 19,88 | 20,51 | +2,24% | 5,70% | 266.793 |
| 20/12/2007 | 19,80 | 20,06 | 19,09 | 20,06 | +2,88% | 4,92% | 488.862 |
| 19/12/2007 | 19,13 | 19,65 | 18,98 | 19,50 | +1,56% | 3,52% | 122.523 |
| 18/12/2007 | 18,98 | 19,31 | 18,23 | 19,20 | +2,60% | 5,72% | 374.728 |
| 17/12/2007 | 18,49 | 18,90 | 18,00 | 18,71 | -0,20% | 4,86% | 148.598 |
| 14/12/2007 | 19,05 | 19,43 | 18,53 | 18,75 | -2,91% | 4,72% | 144.831 |
| 13/12/2007 | 18,42 | 19,43 | 18,27 | 19,31 | +3,20% | 6,30% | 273.926 |
| 12/12/2007 | 19,16 | 19,76 | 18,34 | 18,71 | +2,04% | 7,42% | 520.441 |
| 11/12/2007 | 18,53 | 18,71 | 18,27 | 18,34 | -0,41% | 2,42% | 217.126 |
| 10/12/2007 | 18,34 | 19,13 | 18,19 | 18,42 | +2,71% | 5,10% | 269.571 |
| 07/12/2007 | 18,00 | 18,30 | 17,59 | 17,93 | +0,63% | 3,95% | 136.228 |
| 06/12/2007 | 17,18 | 18,04 | 17,07 | 17,82 | +3,25% | 5,66% | 153.915 |
| 05/12/2007 | 17,44 | 17,44 | 16,92 | 17,26 | +1,54% | 3,00% | 86.054 |
| 04/12/2007 | 17,48 | 17,59 | 16,92 | 16,99 | -3,81% | 3,85% | 146.060 |
| 03/12/2007 | 18,53 | 18,60 | 17,48 | 17,67 | -3,87% | 6,06% | 153.861 |
| 30/11/2007 | 18,68 | 18,90 | 17,82 | 18,38 | -0,20% | 5,81% | 420.413 |
| 29/11/2007 | 17,03 | 18,64 | 16,96 | 18,42 | +8,13% | 9,89% | 329.577 |
| 28/11/2007 | 15,57 | 17,03 | 15,53 | 17,03 | +10,71% | 9,62% | 227.786 |
| 27/11/2007 | 14,64 | 15,80 | 14,64 | 15,38 | +5,39% | 7,93% | 193.135 |
| 26/11/2007 | 16,24 | 16,62 | 14,49 | 14,60 | -9,30% | 13,13% | 146.568 |
| 23/11/2007 | 15,57 | 16,73 | 15,05 | 16,09 | +3,37% | 10,82% | 54.716 |
| 21/11/2007 | 15,53 | 16,06 | 15,16 | 15,57 | -3,48% | 5,78% | 122.817 |